Canada Life’s Ardelyx ARDX Stock Holding History

Canada Life’s Portfolio ARDX Stock Details ARDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$134K	Buy	26,233 +9,113	+53%	+$55.6K	﹤0.01%	1643
2026 Q1	$103K	Sell	17,120 -550	-3%	-$3.64K	﹤0.01%	1687
2025 Q4	$103K	Sell	17,670 -44,252	-71%	-$246K	﹤0.01%	1713
2025 Q3	$349K	Hold	61,922	–	–	﹤0.01%	1644
2025 Q2	$243K	Hold	61,922	–	–	﹤0.01%	1691
2025 Q1	$304K	Buy	61,922 +44,252	+250%	+$238K	﹤0.01%	1682
2024 Q4	$89K	Sell	17,670 -10,010	-36%	-$55.3K	﹤0.01%	1830
2024 Q3	$191K	Sell	27,680 -35,683	-56%	-$211K	﹤0.01%	1787
2024 Q2	$469K	Buy	63,363 +35,683	+129%	+$251K	﹤0.01%	1692
2024 Q1	$202K	Hold	27,680	–	–	﹤0.01%	1829
2023 Q4	$170K	Hold	27,680	–	–	﹤0.01%	1861
2023 Q3	$113K	Buy	27,680 +18,512	+202%	+$72.2K	﹤0.01%	1938
2023 Q2	$31K	Hold	9,168	–	–	﹤0.01%	2069
2023 Q1	$44K	Buy	+9,168	New	+$30.9K	﹤0.01%	2082
2021 Q4	–	Sell	-4,582	Closed	-$6K	–	2506
2021 Q3	$6K	Hold	4,582	–	–	﹤0.01%	2519
2021 Q2	$35K	Hold	4,582	–	–	﹤0.01%	2360
2021 Q1	$30K	Hold	4,582	–	–	﹤0.01%	2441
2020 Q4	$30K	Hold	4,582	–	–	﹤0.01%	2452
2020 Q3	$24K	Hold	4,582	–	–	﹤0.01%	2395
2020 Q2	$32K	Buy	+4,582	New	+$31.9K	﹤0.01%	2378

Other funds holding ARDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Canada Life's ARDX Position: Q2 2026 in Review

Canada Life increased its Ardelyx (ARDX) stake by 53% in Q2 2026, buying an estimated $55.6K and bringing the position to 26,233 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

Canada Life first reported a position in ARDX in Q2 2020 and has held it in 20 quarters since. The position peaked at $469K in Q2 2024. 250 funds tracked by Wall St. Rank hold ARDX as of Q2 2026.

Canada Life held 26,233 shares of Ardelyx worth $134K as of Q2 2026.
Canada Life bought 9,113 Ardelyx shares in Q2 2026, an estimated $55.6K.
Ardelyx made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1643 holding.
Canada Life first reported a position in Ardelyx in Q2 2020 and has held it in 20 quarters since.
Canada Life's Ardelyx position peaked at $469K in Q2 2024.
250 funds tracked by Wall St. Rank held Ardelyx as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.